Ï㽶ÊÓƵ

Whitney K. Hendrickson
( out of 69 reviews )

Whitney K. Hendrickson, MD

Languages spoken: English

Clinical Locations

Ï㽶ÊÓƵ of Utah Hospital

Urogynecology, Area E
Salt Lake City
801-213-2995

  • Dr. Whitney Hendrickson is a fellowship trained Urogynecologist and women’s health provider in the Urogynecology and Pelvic Reconstructive Surgery division.

    Dr. Whitney Hendrickson received her M.D. from Ï㽶ÊÓƵ of Massachusetts. She completed her Obstetrics and Gynecology residency from UC San Diego in San Diego, California. Following residency, Dr. Hendrickson completed a fellowship in Female Pelvic Medicine and Reconstructive Surgery at Duke Ï㽶ÊÓƵ in Durham, North Carolina. Dr. Hendrickson’s clinical interest include the medical and surgical treatment of pelvic organ prolapse and urinary incontinence, especially those women whose initial treatments have not been successful. She offers a robotic minimally invasive approach to prolapse surgery as well as sacral neuromodulation to those with urgency incontinence, fecal incontinence and non-obstructing urinary retention. She is accepting new patients with pelvic floor disorders.

    Dr. Hendrickson’s research interests are in outcomes research, specifically in developing clinical tools to help clinicians and patients make better informed treatment decisions. She has developed predictive tools for urgency urinary incontinence as well as helped to improve predictive tools for post-surgical complications. She is currently a Women’s Reproductive Health Research (WRHR) scholar through the NIH/NICHD where she is studying outcomes after OnbotulinumToxinA and Sacral Neuromodulation for Urgency urinary incontinence.

    Specialties

    Board Certification

    American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)

    Patient Rating

    5.0 /5
    ( out of 69 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 30, 2024
    UH HOSPITALS AND CLINICS

    Thorough and caring

    October 10, 2024
    UH HOSPITALS AND CLINICS

    Dr. Hendrickson is a knowledgeable and kind physician who I trust with my care.

    October 09, 2024
    UH HOSPITALS AND CLINICS

    she is great! very patient and understanding.

    September 28, 2024
    UH HOSPITALS AND CLINICS

    Kind, knowledgable, no impression of being rushed

    July 30, 2024
    UH HOSPITALS AND CLINICS

    She listens and addresses any and all concerns in understandable terms, is knowledgeable, and supportive. This is an excellent medical provider.

    July 17, 2024
    UH HOSPITALS AND CLINICS

    Dr Hendrickson and her Resident Dr. Zoe were very professional and courteous and kind. I quickly felt comfortable and confident in their care.

    June 28, 2024
    UH HOSPITALS AND CLINICS

    My lengthy comments previously on this review should go here - a great experience of being very well cared about & excellent medical care given in a relaxed & thorough visit by Dr Hendrickson & her assistant, Kristen.

    May 23, 2024
    UH HOSPITALS AND CLINICS

    Whitney K Hendrickson is a wonderful caring physician.

    May 15, 2024
    UH HOSPITALS AND CLINICS

    Muy profesional

    See More Patient Comments

  • Dr. Whitney Hendrickson is a fellowship trained Urogynecologist and women’s health provider in the Urogynecology and Pelvic Reconstructive Surgery division.

    Dr. Whitney Hendrickson received her M.D. from Ï㽶ÊÓƵ of Massachusetts. She completed her Obstetrics and Gynecology residency from UC San Diego in San Diego, California. Following residency, Dr. Hendrickson completed a fellowship in Female Pelvic Medicine and Reconstructive Surgery at Duke Ï㽶ÊÓƵ in Durham, North Carolina. Dr. Hendrickson’s clinical interest include the medical and surgical treatment of pelvic organ prolapse and urinary incontinence, especially those women whose initial treatments have not been successful. She offers a robotic minimally invasive approach to prolapse surgery as well as sacral neuromodulation to those with urgency incontinence, fecal incontinence and non-obstructing urinary retention. She is accepting new patients with pelvic floor disorders.

    Dr. Hendrickson’s research interests are in outcomes research, specifically in developing clinical tools to help clinicians and patients make better informed treatment decisions. She has developed predictive tools for urgency urinary incontinence as well as helped to improve predictive tools for post-surgical complications. She is currently a Women’s Reproductive Health Research (WRHR) scholar through the NIH/NICHD where she is studying outcomes after OnbotulinumToxinA and Sacral Neuromodulation for Urgency urinary incontinence.

    Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Primary
    Academic Divisions Urogynecology
    Board Certification
    American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)

    Education history

    Fellowship Female Pelvic Medicine and Reconstructive Surgery - Duke Ï㽶ÊÓƵ Medical Center Fellow
    Gynecology & Reproductive Science - Ï㽶ÊÓƵ of California, San Diego School of Medicine Administrative Chief Resident
    Residency Integrative Medicine Elective - Ï㽶ÊÓƵ of Arizona College of Medicine Visiting Resident
    Obstetrics & Gynecology - Ï㽶ÊÓƵ of California San Diego Medical Center Intern/Resident
    Professional Medical Medicine; concentration in Multicultural Pathways - Ï㽶ÊÓƵ of Massachusetts Medical School M.D.
    Molecular Biology & Biochemistry - Middlebury College B.A.

    Selected Publications

    Journal Article

    1. Hendrickson WK, Zhang C, Jelovsek JE, Nygaard IE, Presson AP (2023). Longitudinal Fluctuations in Treatment Response After OnabotulinumToxinA and Sacral Neuromodulation for Refractory Urgency Incontinence. J Urol, 211(1), 134-143. ()
    2. Hendrickson WK, Zhang C, Jelovsek JE, Nygaard IE, Presson AP (2024). Reply by Authors. J Urol, 211(1), 142-143. ()
    3. Hendrickson WK, Allshouse AA, Nygaard IE, Swenson CW (2023). Overactive Bladder in Late Pregnancy to 1 Year After First Vaginal Delivery. Urogynecology (Phila). ()
    4. Lai HH, Wiseman JB, Helmuth ME, Smith AR, Amundsen CL, Cameron AP, Glaser AP, Hendrickson WK, Kirkali Z, Kenton K (2022). Phenotyping of Urinary Urgency Patients without Urgency Incontinence, and Their Comparison to Urgency Incontinence Patients: Findings from the LURN Study. J Urol, 209(1), 233-242. ()
    5. Kowalski JT, Wiseman JB, Smith AR, Helmuth ME, Cameron A, DeLancey JOL, Hendrickson WK, Jelovsek JE, Kirby A, Kreder K, Lai HH, Mueller M, Siddiqui N, Bradley CS (2022). Natural history of lower urinary tract symptoms in treatment-seeking women with pelvic organ prolapse; the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). Am J Obstet Gynecol, 227(6), 875.e1-875.e12. ()
    6. Hendrickson WK, Xie G, Rahn DD, Amundsen CL, Hokanson JA, Bradley M, Smith AL, Sung VW, Visco AG, Luo S, Jelovsek JE (2021). Predicting outcomes after intradetrusor onabotulinumtoxina for non-neurogenic urgency incontinence in women. Neurourol Urodyn, 41(1), 432-447. ()
    7. Hendrickson WK, Havrilesky L, Siddiqui NY (2021). Cost-effectiveness of bacteriuria screening before urogynecologic surgery. Am J Obstet Gynecol, 226, 831.e1-831.e12. ()
    8. Harvie HS, Sung VW, Neuwahl SJ, Honeycutt AA, Meyer I, Chermansky CJ, Menefee S, Hendrickson WK, Dunivan GC, Mazloomdoost D, Bass SJ, Gantz MG, Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network (2021). Cost-effectiveness of behavioral and pelvic floor muscle therapy combined with midurethral sling surgery vs surgery alone among women with mixed urinary incontinence: results of the Effects of Surgical Treatment Enhanced With Exercise for Mixed Urinary Incontinence randomized trial. Am J Obstet Gynecol, 225(6), 651.e1-651.e26. ()
    9. Hendrickson WK, Amundsen CL, Rahn DD, Meyer I, Bradley MS, Smith AL, Myers DL, Jelovsek JE, Lukacz ES (2021). Comparison of 100 U With 200 U of Intradetrusor OnabotulinumToxinA for Nonneurogenic Urgency Incontinence. Female Pelvic Med Reconstr Surg, 27(3), 140-146. ()
    10. Hendrickson WK, Amundsen CL (2021). Sacral neuromodulation: troubleshooting needle placement. Int Urogynecol J, 32, 2549-2551. ()
    11. Hendrickson WK, Amundsen CL (2020). Sacral neuromodulation: sacral anatomy and optimal lead placement. Int Urogynecol J, 32, 2545-2547. ()
    12. Hendrickson WK, Amundsen CL (2019). 2019 Update on pelvic floor dysfunction: review of fecal incontinence treatments. 31(9), 23, 24, 26-30.
    13. Downey JS, Mashburn-Warren L, Ayala EA, Senadheera DB, Hendrickson WK, McCall LW, Sweet JG, Cvitkovitch DG, Spatafora GA, Goodman SD (2014). In vitro manganese-dependent cross-talk between Streptococcus mutans VicK and GcrR: implications for overlapping stress response pathways. PLoS One, 9(12), e115975. ()
    14. Flavin R, Pettersson A, Hendrickson WK, Fiorentino M, Finn S, Kunz L, Judson GL, Lis R, Bailey D, Fiore C, Nuttall E, Martin NE, Stack E, Penney KL, Rider JR, Sinnott J, Sweeney C, Sesso HD, Fall K, Giovannucci E, Kantoff P, Stampfer M, Loda M, Mucci LA (2014). SPINK1 protein expression and prostate cancer progression. Clin Cancer Res, 20(18), 4904-11. ()
    15. Kasperzyk JL, Finn SP, Flavin R, Fiorentino M, Lis R, Hendrickson WK, Clinton SK, Sesso HD, Giovannucci EL, Stampfer MJ, Loda M, Mucci LA (2013). Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev, 22(12), 2354-63. ()
    16. Hendrickson WK, Flavin R, Kasperzyk JL, Fiorentino M, Fang F, Lis R, Fiore C, Penney KL, Ma J, Kantoff PW, Stampfer MJ, Loda M, Mucci LA, Giovannucci E (2011). Vitamin D receptor protein expression in tumor tissue and prostate cancer progression. J Clin Oncol, 29(17), 2378-85. ()
    17. Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, Fall K, Ma J, Gaziano JM, Stampfer MJ, Mucci LA, Giovannucci E (2011). Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One, 6(4), e18625. ()

    Book Chapter

    1. Whitney K Hendrickson and Matthew D Barber (). Chapter 19: Surgical Treatment of Anterior Vaginal Wall Prolpase. In Matthew D. Barber; Mark D. Walters; Mickey M. Karram; Catherine Bradley (Ed.), Walters & Karram Urogynecology and Reconstructive Pelvic Surgery (6th). Elsevier.
    2. Hendrickson WK and MD Barber (2023). Chapter 8.2 Anterior Vaginal Wall Prolapse. In Linda Cardozo, M.D. and David R. Staskin, M.D (Eds.), Textbook of Female Urology and Urogynecology: Surgical Perspectives (5th ed). CRC Press.

    Letter

    1. Swenson CW, Hendrickson WK, Allshouse AA, Nygaard IE (2024). Older maternal age at first vaginal delivery is associated with increased genital hiatus size at 1 year postpartum. [Letter to the editor]. Am J Obstet Gynecol, 230(6), e110-e112. ()

  • News & Podcasts

    Podcasts